Francesco Sartini

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Optical Coherence Tomography

Surgical Site Infection

Coronary Artery Bypass

Top Venues

Eye (London, England)

Journal of clinical medicine

Pharmaceuticals (Basel, Switzerland)

Acta ophthalmologica

This page only lists publications with an associated author ORCID identifier.

Publications

Pasquale Loiudice, Andrea Montesel, Francesco Sartini, Riccardo Morganti, Chiara Posarelli, Marco Nardi, Michele Figus, Giamberto Casini
Reply to: Comment on: Localized versus 360° intraoperative laser retinopexy in cases of rhegmatogenous retinal detachment with mild-to-moderate grade proliferative vitreoretinopathy. Eye (London, England) 35 (11) (2021)
Francesco Sartini, Martina Menchini, Pasquale Loiudice, Marco Nardi, Michele Figus, Giamberto Casini
Surgical technique for removing vitreous cortex remnants using a diamond-dusted membrane scraper. Acta ophthalmologica (2021)
Chiara Posarelli, Francesco Sartini, Giamberto Casini, Andrea Passani, Mario Domenico Toro, Giovanna Vella, Michele Figus
What Is the Impact of Intraoperative Microscope-Integrated OCT in Ophthalmic Surgery? Relevant Applications and Outcomes. A Systematic Review. Journal of clinical medicine 9 (6) (2020)
Francesco Sartini, Martina Menchini, Chiara Posarelli, Giamberto Casini, Michele Figus
Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Pasquale Loiudice, Andrea Montesel, Francesco Sartini, Riccardo Morganti, Chiara Posarelli, Marco Nardi, Michele Figus, Giamberto Casini
Localized versus 360° intraoperative laser retinopexy in cases of rhegmatogenous retinal detachment with mild-to-moderate grade proliferative vitreoretinopathy. Eye (London, England) 35 (3) (2020)
Francesco Sartini, Michele Figus, Marco Nardi, Giamberto Casini, Chiara Posarelli
Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options. Eye (London, England) 33 (7) (2019)